Valuation: Carmat SA

Market Cap 6.15M 6.9M 5.69M 5.15M 9.7M 651M 9.82M 68.22M 26.77M 342M 25.87M 25.33M 1.09B P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 59.25M 66.49M 54.85M 49.64M 93.52M 6.27B 94.63M 658M 258M 3.3B 249M 244M 10.51B EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Current year 0.1
Extreme 0.099
0.1
1 year 0.1
Extreme 0.099
0.1
3 years 0.08
Extreme 0.085
9.99
5 years 0.08
Extreme 0.085
29.5
10 years 0.08
Extreme 0.085
40.06
Manager TitleAgeSince
Chief Executive Officer 55 2016-08-31
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2025-03-31
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 2017-01-01
Director/Board Member 79 2017-04-19
Date Insider Type Main position Quantity % Market Cap. Importance
3/13/25 Sell

Chairman

1,343,333 2.3347%
3/13/25 Buy

Chairman

1,343,333 2.3347%
5/29/24 Buy

Director

1,343,333 4.6122%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-96.82% 7.08M
-3.35%-3.70%-22.25%+3.53% 177B
-3.17%+5.51%-21.76%+12.73% 117B
-2.00%-0.93%-2.59%+28.95% 116B
+15.48%+17.35%-45.10%+5.02% 77.71B
-0.84%+1.21%+3.47%+80.19% 65.51B
+1.98%+4.70%+17.36%+81.35% 54.97B
+0.10%+3.09%+3.01%-23.92% 52.79B
-0.52%+5.32%-12.65%+30.11% 43.95B
-5.24%-1.80%+17.52%-4.71% 32.35B
Average +0.21%+3.03%-6.30%+11.64% 73.72B
Weighted average by Cap. -0.20%+3.03%-12.13%+21.01%

Financials

2023 2024
Net sales 3.84M 4.31M 3.55M 3.21M 6.06M 406M 6.13M 42.59M 16.71M 214M 16.15M 15.82M 681M 7.34M 8.24M 6.8M 6.15M 11.59M 778M 11.73M 81.52M 31.99M 409M 30.92M 30.27M 1.3B
Net income -53.87M -60.45M -49.87M -45.13M -85.03M -5.7B -86.04M -598M -235M -3B -227M -222M -9.56B -51.4M -57.68M -47.58M -43.06M -81.13M -5.44B -82.09M -571M -224M -2.86B -216M -212M -9.12B
Net Debt 49.64M 55.7M 45.95M 41.59M 78.35M 5.26B 79.28M 551M 216M 2.76B 209M 205M 8.8B 53.1M 59.59M 49.16M 44.49M 83.82M 5.62B 84.81M 589M 231M 2.96B 224M 219M 9.42B
Projected Income Statement - Annual - Carmat SA
Logo Carmat SA
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153
  1. Stock Market
  2. Stocks
  3. ALCAR Stock